INS and metabolic dysfunction-associated steatotic liver disease: Furthermore, by using material from different donors, for instance, with and without T2DM, NAFLD or metabolic syndrome, the established model provides an appealing system to parse the molecular basis for interindividual differences in insulin sensitivity and secretion across the glucometabolic spectrum, which are known to be extensive.[110]